Prospect News: News for Pharmacyclics, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with P > Issuers starting with P, PP only > All stories on Pharmacyclics, Inc. > Stories on Pharmacyclics, Inc., PP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Pharmacyclics, Inc.

6/17/2011	PP	Pharmacyclics inks $57.07 million registered direct offering of shares
6/17/2010	PP	New Issue: Pharmacyclics lifts registered direct offering of stock to $52 million
6/17/2010	PP	Market Commentary: Pharmacyclics ups direct offering; Celsion gets equity facility; China Power seals $10 million
6/16/2010	PP	Market Commentary: Pharmacyclics brings offering; Kayne Anderson settles two deals; BNC adds Aquiline as investor
6/16/2010	PP	New Issue: Pharmacyclics arranges $40 million registered direct offering of stock
2/23/2009	PP	New Issue: Pharmacyclics settles $1.4 million private placement of stock
2/23/2009	PP	Market Commentary: Apollo completes $70 million deal; Queenston to raise C$18 million; Po Valley to issue stock
8/21/2006	PP	Market Commentary: Inverness secures $151.25 million from stock offering; Oscient, unit completes private placements
8/21/2006	BTPP	New Issue: Pharmacyclics receives $20 million equity line

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.